Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Stachon, P; Kaier, K; Milde, S; Pache, G; Sorg, S; Siepe, M; von zur Mühlen, C; Zirlik, A; Beyersdorf, F; Langer, M; Zehender, M; Bode, C; Reinöhl, J.
Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.
EUR HEART J-CARD IMG. 2015; 16(7): 731-737.
Doi: 10.1093/ehjci/jev055
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Zirlik Andreas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Recently, transcatheter aortic valve replacement (TAVR) has evolved as the standard treatment in patients with inoperable aortic valve stenosis. According to TAVR guidelines, body computed tomography (CT) is recommended for pre-procedural planning. Due to the advanced age of these patients, multiple radiological potentially malignant incidental findings (pmIFs) appear in this cohort. It is unknown how pmIFs influence the decision by the heart team to intervene and the mortality. We evaluated in a retrospective single-centre observational study 414 participants screened for TAVR with dual-source CT between October 2010 and December 2012. pmIFs are common and appeared in 18.7% of all patients screened for TAVR. The decision to intervene by TAVR or surgical aortic valve replacement (SAVR) was made by an interdisciplinary heart team and the role of pmIF in decision-making and time to treatment with TAVR or SAVR was analysed, retrospectively. The appearance of a pmIF vs. no pmIF did not significantly influence therapeutic decisions [odds ratio (OR) 1.14; P = 0.835] or time to treatment (91 ± 152 vs. 61 ± 109 days, respectively). Several findings, which are highly suspicious for malignancy, were less likely associated with invasive treatment (OR 0.207; P = 0.046). Patient survival was evaluated for at least 2 years until January 2014. Two-year survival of patients after TAVR or SAVR, treated according to the heart team decision, was ∼75% and independent from the presence of a non-severe (P = 0.923) or severe (P = 0.823) pmIF. The study indicates that frequently occurring radiologic pmIF did not influence 2-year survival after a decision to intervene was made by an interdisciplinary heart team. © The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Aortic Valve Stenosis - diagnostic imaging
- Aortic Valve Stenosis - epidemiology
- Aortic Valve Stenosis - surgery
- Cohort Studies -
- Female -
- Humans -
- Incidental Findings -
- Kaplan-Meier Estimate -
- Male -
- Middle Aged -
- Neoplasms - diagnostic imaging
- Neoplasms - mortality
- Preoperative Care - methods
- Prognosis -
- Proportional Hazards Models -
- Retrospective Studies -
- Risk Assessment -
- Statistics, Nonparametric -
- Survival Analysis -
- Time Factors -
- Tomography, X-Ray Computed - methods
- Transcatheter Aortic Valve Replacement - methods
- Transcatheter Aortic Valve Replacement - mortality
- Treatment Outcome -
- Ultrasonography -
- Find related publications in this database (Keywords)
- aortic valve stenosis
- aortic valve replacement
- TAVR
- TAVI
- incidental finding
- malignancy
- cancer
- mortality
- computed tomography